Nursing practice questions with comprehensive rationales
NurseDive Free Nursing Practice Question
A nurse is creating a plan of care for a newborn who is breastfed and appears jaundiced.
Which of the following interventions should the nurse include?
A. Place the newborn under a radiant warmer.
Placing the newborn under a radiant warmer is not directly related to addressing breastfeeding-related jaundice.
B. Supplement breastfeeding with iron-fortified formula.
Supplementing breastfeeding with formula is not the first-line approach and may interfere with establishing successful breastfeeding.
C. Determine the effectiveness of breastfeeding.
Breastfeeding-related jaundice can occur if the newborn is not effectively breastfeeding and not getting enough milk. Assessing the effectiveness of breastfeeding is important to address the underlying cause of jaundice.
D. Administer Rho(D) immune globin to the newborn.
Administering Rho(D) immune globulin is unrelated to addressing jaundice in a breastfed newborn.
This question is an excerpt from Nurse Dive's nursing test bank - RN ati Concept-based assessment level proctored exam. Take the full exam now
Full Explanation
Choice A rationale:
Placing the newborn under a radiant warmer is not directly related to addressing breastfeeding-related jaundice.
Choice B rationale:
Supplementing breastfeeding with formula is not the first-line approach and may interfere with establishing successful breastfeeding.
Choice C rationale:
Breastfeeding-related jaundice can occur if the newborn is not effectively breastfeeding and not getting enough milk. Assessing the effectiveness of breastfeeding is important to address the underlying cause of jaundice.
Choice D rationale:
Administering Rho(D) immune globulin is unrelated to addressing jaundice in a breastfed newborn.
Similar Questions
A nurse is planning teaching for a client who has multiple sclerosis. Which of the following instructions should the nurse plan to include?
A. Take a hot bath to relieve muscle spasms.
Taking a hot bath to relieve muscle spasms might exacerbate symptoms in individuals with multiple sclerosis due to heat sensitivity.
B. Participate in high-impact exercise daily.
Participating in high-impact exercise daily can be challenging for individuals with multiple sclerosis, who may experience fatigue and mobility issues.
C. Drink at least 1.5 L of fluid per day.
Adequate hydration is essential for individuals with multiple sclerosis to maintain overall health and support neurological function.
D. Restrict daily intake of dietary fiber.
Restricting daily intake of dietary fiber is not recommended, as fiber can aid in maintaining bowel regularity for individuals with multiple sclerosis.
Full Explanation
Choice A rationale:
Taking a hot bath to relieve muscle spasms might exacerbate symptoms in individuals with multiple sclerosis due to heat sensitivity.
Choice B rationale:
Participating in high-impact exercise daily can be challenging for individuals with multiple sclerosis, who may experience fatigue and mobility issues.
Choice C rationale:
Adequate hydration is essential for individuals with multiple sclerosis to maintain overall health and support neurological function.
Choice D rationale:
Restricting daily intake of dietary fiber is not recommended, as fiber can aid in maintaining bowel regularity for individuals with multiple sclerosis.
A nurse is caring for a newly admitted client who has acute inflammatory bowel disease with constipation and reports bloody stools. Which of the following medications should the nurse plan to administer?
A. Omeprazole
Omeprazole is a proton pump inhibitor used to reduce stomach acid production and is not typically used for treating bloody stools in inflammatory bowel disease.
B. Infliximab
Infliximab is used to treat inflammatory bowel disease and can help manage symptoms such as bloody stools by suppressing the inflammatory response.
C. Ondansetron
Ondansetron is an antiemetic used for nausea and vomiting, not related to bloody stools.
D. Metoclopramide
Metoclopramide is used to treat nausea, vomiting, and gastrointestinal motility disorders, not specifically indicated for bloody stools.
Full Explanation
Choice A rationale
Omeprazole is a proton pump inhibitor used to reduce stomach acid production and is not typically used for treating bloody stools in inflammatory bowel disease.
Choice B rationale:
Infliximab is used to treat inflammatory bowel disease and can help manage symptoms such as bloody stools by suppressing the inflammatory response.
Choice C rationale:
Ondansetron is an antiemetic used for nausea and vomiting, not related to bloody stools.
Choice D rationale:
Metoclopramide is used to treat nausea, vomiting, and gastrointestinal motility disorders, not specifically indicated for bloody stools.
A nurse is reviewing the laboratory results of a client who has Parkinson's disease and a prescription for carbidopa/levodopa. Which of the following values should the nurse report to the provider?
A. Fasting blood glucose 96 mg/dL
A fasting blood glucose level of 96 mg/dL is within a normal range and is not typically associated with carbidopa/levodopa therapy.
B. Hemoglobin 10 g/dL
Hemoglobin levels of 10 g/dL may indicate anemia, which can exacerbate symptoms in clients with Parkinson's disease and affect the effectiveness of carbidopa/levodopa.
C. Platelet count 200,000/mm3
A platelet count of 200,000/mm3 is within a normal range and is not typically associated with carbidopa/levodopa therapy.
D. BUN 10 mg/dL
A blood urea nitrogen (BUN) level of 10 mg/dL is within a normal range and is not typically associated with carbidopa/levodopa therapy.
Full Explanation
Choice A rationale:
A fasting blood glucose level of 96 mg/dL is within a normal range and is not typically associated with carbidopa/levodopa therapy.
Choice B rationale:
Hemoglobin levels of 10 g/dL may indicate anemia, which can exacerbate symptoms in clients with Parkinson's disease and affect the effectiveness of carbidopa/levodopa.
Choice C rationale:
A platelet count of 200,000/mm3 is within a normal range and is not typically associated with carbidopa/levodopa therapy.
Choice D rationale:
A blood urea nitrogen (BUN) level of 10 mg/dL is within a normal range and is not typically associated with carbidopa/levodopa therapy.